IP Verse

Chiesi Farmaceutici patent opposition analysis

Get complete Patent Opposition Report for Chiesi Farmaceutici

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Chiesi Farmaceutici

Explore patent oppositions filed by Chiesi Farmaceutici against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3471805Drug Delivery Device With ElectronicsNORTON WATERFORDFeb 14, 2020
EP2897588An Inhalable MedicamentTEVA BRANDED PHARMACEUTICAL PRODUCTS R & DFeb 6, 2020
EP3344607Solid State Forms Of SelexipagTEVA PHARMACEUTICALSFeb 6, 2020
EP1646417Inhaler ApparatusCIPLA EUAug 8, 2019
EP2824174Mesenchymal Stem Cells And Uses ThereforMESOBLASTAug 7, 2019
EP3071272Inhaler DeviceCIPLAAug 5, 2019

Latest patents of Chiesi Farmaceutici opposed by its competitors

Explore Chiesi Farmaceutici's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2104490Jun 26, 2024Micronised Particles Of Low-Dosage Strength Active Agents For Powder Formulations For Inhalation1
EP3500241Oct 4, 2023Combination Therapy For Copd3
EP2890437Dec 18, 2019Aerosol Inhalation Device2
EP3384931Jul 24, 2019Formoterol Superfine Formulation1
EP3034073Jun 12, 2019Use Of A Composition Comprising Formoterol And Beclometasone Dipropionate For The Prevention And/Or Treatment Of An Exacerbation Of Asthma3
EP3019153Sep 5, 2018Dry Powder Formulation Comprising An Anticholinergic, A Corticosteroid And A Beta-Adrenergic For Administration By Inhalation1
EP2806855Jul 11, 2018Dry Powder Formulation Comprising A Corticosteroid And A Beta-Adrenergic For Administration By Inhalation1
EP2552424May 9, 2018Process For Preparing Carrier Particles For Dry Powders For Inhalation2
EP2560611Jan 3, 2018"Process For Providing Particles With Reduced Electrostatic Charges"1
EP1294379Apr 1, 2009A New Use For Deferiprone2

Top competitors of Chiesi Farmaceutici